Matthew Korenberg
Fortuna: 448 294 $ al 31/07/2026
Fortuna: 448 294 $ al 31/07/2026
Matthew Edward Korenberg was the founder of Neurocircuit Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer & Director.
Current jobs include Director at Qualigen, Inc.; Director at The Pelican, Inc. since 2020; Director at Ligand UK Group Ltd. since 2018; Independent Director at Lifecore Biomedical, Inc. since 2024; and Chief Financial Officer, Secretary & Treasurer at Palvella Therapeutics, Inc. since 2024.
Former jobs include Director at Ligand UK Ltd.; Managing Director at Goldman Sachs & Co. LLC.
from 1999 to 2013; Independent Director at AIxCrypto Holdings, Inc. from 2020 to 2024; Director at Ligand UK Research Ltd.; and President & Chief Operating Officer at Ligand Pharmaceuticals, Inc. from 2022 to 2024.
Education includes undergraduate studies at the University of Michigan.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/06/2026 | 69.967 ( 0,19 % ) | 309 254 $ | 31/07/2026 | |
0,01 % | 12/06/2026 | 1.000 ( 0,01 % ) | 139 040 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PFENEX INC. | Director/Miembro de la Junta | 01/10/2020 |
| LIFECORE BIOMEDICAL, INC. | Director/Miembro de la Junta | 01/08/2024 |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Miembro de la Junta | 12/10/2018 |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Presidente | 31/10/2024 |
| AIXCRYPTO HOLDINGS, INC. | Director/Miembro de la Junta | 03/10/2024 |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Miembro de la Junta | 19/03/2024 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/08/2013 |
| VERNALIS | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
Ligand UK Ltd.
Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Neurocircuit Therapeutics, Inc. | |
Qualigen Therapeutics, Inc.
Qualigen Therapeutics, Inc. Packaged SoftwareTechnology Services Develops global ecosystem platform that integrates AI and blockchain systems to connect web apps | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.